Response to Gultekin et al. regarding SECRAB trial toxicity

Research output: Contribution to journalArticle

Standard

Response to Gultekin et al. regarding SECRAB trial toxicity. / Fernando, Indrajit N.; Lax, Sian; Ahmed, Ikhlaaq.

In: Radiotherapy and Oncology, 08.02.2020.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Bibtex

@article{6c9b74fd128f41b58bf2a0e6ec9da180,
title = "Response to Gultekin et al. regarding SECRAB trial toxicity",
author = "Fernando, {Indrajit N.} and Sian Lax and Ikhlaaq Ahmed",
year = "2020",
month = feb
day = "8",
doi = "https://doi.org/10.1016/j.radonc.2020.01.019",
language = "Undefined/Unknown",
journal = "Radiotherapy & Oncology",
issn = "0167-8140",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Response to Gultekin et al. regarding SECRAB trial toxicity

AU - Fernando, Indrajit N.

AU - Lax, Sian

AU - Ahmed, Ikhlaaq

PY - 2020/2/8

Y1 - 2020/2/8

U2 - https://doi.org/10.1016/j.radonc.2020.01.019

DO - https://doi.org/10.1016/j.radonc.2020.01.019

M3 - Article

JO - Radiotherapy & Oncology

JF - Radiotherapy & Oncology

SN - 0167-8140

ER -